标题
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-03-02
DOI
10.3389/fimmu.2018.00398
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult
- (2018) Tyler J. Loftus et al. CURRENT OPINION IN HEMATOLOGY
- PD-1 pathway and its clinical application: A 20 year journey after discovery of the complete human PD - 1 gene
- (2018) Kristin Nicole Berger et al. GENE
- Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
- (2017) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Energy metabolic pathways control the fate and function of myeloid immune cells
- (2017) Amir A. Al-Khami et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients
- (2017) Richard P. Tobin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
- (2017) Jessica C. Hassel et al. OncoImmunology
- Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
- (2017) Amir A. Al-Khami et al. OncoImmunology
- Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
- (2016) Q. Zhang et al. BLOOD
- Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy
- (2016) Michal Baniyash CANCER IMMUNOLOGY IMMUNOTHERAPY
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
- (2016) M. Sade-Feldman et al. CLINICAL CANCER RESEARCH
- Exosomes: The Messengers of Health and Disease
- (2016) Allison Isola et al. Current Neuropharmacology
- Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- (2016) Emma Eriksson et al. Journal of Translational Medicine
- Myeloid-derived suppressor cells and tumor escape from immune surveillance
- (2016) Viktor Umansky et al. Seminars in Immunopathology
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
- (2016) Thibaud Spinetti et al. OncoImmunology
- Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
- (2015) Gaute Lund Hansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2015) J. A. Califano et al. CLINICAL CANCER RESEARCH
- Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
- (2015) C. Gebhardt et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
- (2015) H.-M. Chen et al. CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment
- (2015) Wei Pan et al. TUMOR BIOLOGY
- Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
- (2015) F. Hossain et al. Cancer Immunology Research
- Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate
- (2015) Yaron Meirow et al. Frontiers in Immunology
- Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
- (2015) Kirsten Ridder et al. OncoImmunology
- Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
- (2015) Oana Draghiciu et al. OncoImmunology
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes
- (2014) J. Kanterman et al. CANCER RESEARCH
- Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2014) D. T. Weed et al. CLINICAL CANCER RESEARCH
- Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
- (2014) Huanhuan Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Conversion of Tyrosine to the Inflammation-Associated Analog 3′-Nitrotyrosine at Either TCR- or MHC-Contact Positions Can Profoundly Affect Recognition of the MHC Class I-Restricted Epitope of Lymphocytic Choriomeningitis Virus Glycoprotein 33 by CD8 T Cells
- (2014) Lani L. Hardy et al. JOURNAL OF IMMUNOLOGY
- Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
- (2014) M. C. B. Tan et al. JOURNAL OF IMMUNOLOGY
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB
- (2014) Amy Chow et al. Scientific Reports
- Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab
- (2014) Saskia JAM Santegoets et al. Journal for ImmunoTherapy of Cancer
- Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
- (2013) Cristina Iclozan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Increased circulating Lin−/lowCD33+HLA-DR−myeloid-derived suppressor cells in hepatocellular carcinoma patients
- (2013) Peng Shen et al. HEPATOLOGY RESEARCH
- Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling
- (2013) Niko P. Bretz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation
- (2013) Anuradha Ray et al. Frontiers in Cellular and Infection Microbiology
- Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
- (2013) Y. P. de Coana et al. Cancer Immunology Research
- Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
- (2013) Robert Wesolowski et al. Journal for ImmunoTherapy of Cancer
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
- (2012) M. Platten et al. CANCER RESEARCH
- CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
- (2012) M. Velasco-Velazquez et al. CANCER RESEARCH
- Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner
- (2012) Tillmann Michels et al. Journal of Immunotoxicology
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Recent advances on the role of tumor exosomes in immunosuppression and disease progression
- (2012) Paola Filipazzi et al. SEMINARS IN CANCER BIOLOGY
- Hypoxia-driven immunosuppression contributes to the pre-metastatic niche
- (2012) Jaclyn Sceneay et al. OncoImmunology
- Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL
- (2011) P. Sinha et al. BLOOD
- 2011: the immune hallmarks of cancer
- (2011) Federica Cavallo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
- (2011) A. M. Lesokhin et al. CANCER RESEARCH
- Myeloid cell population dynamics in healthy and tumor-bearing mice
- (2011) Satoshi Ueha et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer
- (2011) Evgeniy Eruslanov et al. INTERNATIONAL JOURNAL OF CANCER
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts
- (2011) Héctor Peinado et al. SEMINARS IN CANCER BIOLOGY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
- (2010) Fanny Chalmin et al. JOURNAL OF CLINICAL INVESTIGATION
- An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
- (2010) J. D. Mezrich et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models
- (2010) B. Yin et al. JOURNAL OF IMMUNOLOGY
- CCR5 Proinflammatory Allele in Prostate Cancer Risk
- (2009) Carmela Rita Balistreri et al. Annals of the New York Academy of Sciences
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
- (2009) L. Izhak et al. JOURNAL OF IMMUNOLOGY
- A Novel Recombinant Fusion Protein Encoding a 20-Amino Acid Residue of the Third Extracellular (E3) Domain of CCR2 Neutralizes the Biological Activity of CCL2
- (2009) L. Izhak et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Escape Mechanism Governed by Myeloid-Derived Suppressor Cells
- (2008) S. Nagaraj et al. CANCER RESEARCH
- Immune surveillance: a balance between protumor and antitumor immunity
- (2008) Suzanne Ostrand-Rosenberg CURRENT OPINION IN GENETICS & DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started